PARP Inhibitor Projects

PARP inhibitor projects funded by the Rivkin Center

The Rivkin Center for Ovarian Cancer has funded numerous studies over the years that have contributed to our understanding of PARP inhibitors including resistance to PARP inhibitors, novel approaches to increase effectiveness of treatment and the development of research tools that have brought the field to where it is today. We continue to fund studies that will help improve current treatments and develop new options. Here are PARP inhibitor-related studies funded by the Rivkin Center to date: